<DOC>
	<DOCNO>NCT01367561</DOCNO>
	<brief_summary>This double-blind , randomize , study single clinical site investigate effect methylnaltrexone naloxone versus placebo healthy male receive short-acting opioid , remifentanil .</brief_summary>
	<brief_title>Naloxone Intravenous Methylnaltrexone Effects Bladder Function</brief_title>
	<detailed_description />
	<mesh_term>Naloxone</mesh_term>
	<mesh_term>Methylnaltrexone</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>1 . Healthy male , 18 65 yr normal urinary function 2 . Body weight less 150 kg Body Mass Index 2032 . 1 . Females 2 . History drug alcohol abuse 3 . History significant chronic illness ( cardiovascular , gastrointestinal , pulmonary , neurologic , endocrine , renal , hepatic , etc . ) 4 . Subjects receive opioids one week long last 2 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2011</verification_date>
</DOC>